Precision Medicine May Have a New Lung Cancer Treatment That Can Be Staged With an EGFR Test as a Companion Diagnostic
Yale researchers find that an AstraZeneca cancer pill improves survival rates when taken after lung cancer surgery.
Oncology and Cancer Care
Machine Learning Algorithm May Work Better As An Ensemble for Ovarian Cancer Precision Medicine
Georgia Tech researchers applied a different approach to their machine learning algorithm to predict what medications would best treat different ovarian cancers.
Sound Wave Therapy for Tumors Tested in Liver Cancer
Healthcare leaders will want to follow the nascent field of sound wave therapy as more research and the findings of clinical trials emerge.
Liquid Biopsy Research, Collaborations, Advancements Continue Forward March for Oncology Precision Medicine in 2022
Precision Medicine Institute’s noted of liquid biopsy research, collaborations, and advancements as 2022 approaches year-end.
Deadly Pancreatic Tumors Can Now Be Detected Earlier, New Precision Medicine Research Shows
Where AI and molecular testing are showing new methods of detecting pancreatic cancers before they become more advanced.
California to Become Sixth State to Cover Cancer Biomarker Testing, But Precision Medicine Screenings Are Not Included
More states are focusing on cancer biomarker testing for payer coverage requirements.
Liquid Biopsy Enables Detection and Treatment of Liver Cancer While It Can Still Be Cured
Recent research into liquid biopsies has resulted in a new blood test that can detect liver cancer while it is still in an early stage.
Precision Medicine May Help 50-Year-Old Cancer Drug Bring More Accurate Treatment, New Research Shows
Hospitals and oncology groups may be able to apply modern precision medicine principles to a 50-year-old cancer drug, increasing the drug’s effectiveness for breast cancer patients.
University of Florida Scientists Use Genetics to Develop Precision Medicine Score for Children’s Leukemia Treatments
Method genetically defines patients who would benefit from intensifying the chemotherapy, adding a new drug, or having chemotherapy reduced to avoid toxicity.
Cornell Researchers Have Discovered Precision Medicine Treatment That Overcomes Chemotherapy-Resistant Gastric Cancer
Researchers at Weill Cornell Medicine believe they have discovered the variant protein that causes taxane-resistant cancer cells to develop.